[CHARGE syndrome].

Area of Science:

• Genetics and Molecular Biology
• Developmental Biology
• Clinical Medicine

Background:

• CHARGE syndrome is a complex genetic disorder characterized by a specific set of anomalies.
• Mutations in the Chromodomain Helicase DNA-binding protein 7 (CHD7) gene are identified as the primary cause in approximately 60% of diagnosed cases.
• The condition affects approximately 1 in 10,000 live births, highlighting its rarity and clinical significance.

Observation:

• This report focuses on three unrelated pediatric patients presenting with a clinical diagnosis of CHARGE syndrome.
• Each patient exhibited a unique, previously undescribed mutation within the CHD7 gene sequence.
• The observed mutations were identified through genetic analysis of the affected individuals.

Findings:

• The study confirms the critical role of the CHD7 gene in the etiology of CHARGE syndrome.
• Identification of distinct mutations in three separate patients underscores the genetic heterogeneity associated with the condition.
• The findings reinforce the correlation between CHD7 gene mutations and the characteristic phenotypic spectrum of CHARGE syndrome.

Implications:

• These findings contribute to a deeper understanding of the molecular mechanisms underlying CHARGE syndrome.
• Accurate genetic diagnosis through CHD7 mutation analysis can aid in clinical management and genetic counseling.
• Further research into genotype-phenotype correlations may improve diagnostic accuracy and therapeutic strategies for affected individuals.